Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Short/dysfunctional telomeres are at the origin of idiopathic pulmonary fibrosis (IPF) in patients mutant for telomere maintenance genes. However, it remains unknown whether physiological aging leads to short telomeres in the lung, thus leading to IPF with aging. Here, we find that physiological aging in wild-type mice leads to telomere shortening and a reduced proliferative potential of alveolar type II cells and club cells, increased cellular senescence and DNA damage, increased fibroblast activation and collagen deposits, and impaired lung biophysics, suggestive of a fibrosis-like pathology. Treatment of both wild-type and telomerase-deficient mice with telomerase gene therapy prevented the onset of lung profibrotic pathologies. These findings suggest that short telomeres associated with physiological aging are at the origin of IPF and that a potential treatment for IPF based on telomerase activation would be of interest not only for patients with telomerase mutations but also for sporadic cases of IPF associated with physiological aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Telomerase deficiency and natural aging in the mouse lung leads to telomere shortening and reduction in the number of ATII and club cells. (A and B) Generation of Tert+/+ and G3 Tert−/− mice and scheme of lung tissue harvesting. (A) Heterozygous Tert+/− mice were crossed to obtain Tert+/+ and G1 Tert−/− mice, and successive crosses between G1 Tert−/− and then G2 Tert−/− mice were made to generate G3 Tert−/− mice. (B) Scheme of sacrifice and collection of lungs from Tert+/+ and G3 Tert−/− mice at different time points. (C) Representative images showing a Q-FISH for telomere spot fluorescence in ATII and club cells (Cy3Tel probe [red], SFTPC- and SCGB1A1-positive cells [green]) and nuclei stained with DAPI (blue; left and center right), SFTPC (brown, red arrowheads; center left), and SCGB1A1 (brown, green arrowheads; right) immunostainings in lung sections from Tert+/+ and G3 Tert−/− at different time points. (D–I) Quantification of mean telomere fluorescence (mean spot intensity; D and F), percentage of short telomeres in ATII and club cells corresponding to the 20th percentile of the fluorescence intensity values of controls (5-wk-old Tert+/+ mice; E and G), and SFTPC-positive ATII cells (%) and SCGB1A1-positive club cells per epithelium length (millimeters; H and I). Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.](https://figures.cochat.ai/paper-figures/7291dc599f4d484faf0785adf7b35579/telomerase-treatment-prevents-lung-profibrotic-pathologies-associated-with-figure-1.jpg)



![Figure 5. Physiological aging leads to impaired surfactant activity which is partially restored by telomerase gene therapy in both wild-type mice and telomerase-deficient mice. (A and B) Captive bubble results from Tert+/+ and G3 Tert−/− mice with increasing weeks of age. (C and D) Captive bubble results from 71–72-wk-old Tert+/+ and G3 Tert−/− mice treated with AAV9-empty or AAV9-Tert. (A and C) Top: Surface tension obtained 1 s after applying surfactant onto the air bubble (initial adsorption). Bottom: Surface tension obtained 1 s after the bubble expansion (postexpansion [PE] adsorption). (B and D) Top: Representative γ-relative area isotherms obtained under breathing-like dynamic cycles for each group tested. Bottom: Minimum and maximum γ along with the relative area of compression obtained during the 20th cycle. White bars represent Tert+/+ mice. Gray bars represent G3 Tert−/− mice. Data are expressed as mean ± SEM (n = 5–6 animals per group). *, P < 0.05; **, P < 0.01. Between different ages for each condition: One-way ANOVA with post hoc Dunn–Sidak multiple comparison test. Between different conditions within the same age: following a Shapiro–Wilk normality test, two-sample unpaired t test, or Mann–Whitney test when appropriate. γ, surface tension; max, maximum; min, minimum.](https://figures.cochat.ai/paper-figures/83a7bf0506ee43e09cb6b02a43e86288/telomerase-treatment-prevents-lung-profibrotic-pathologies-associated-with-figure-5.jpg)

![Figure 6. Telomerase gene therapy in the mouse lung results in telomere elongation and increased number of ATII and club cells. (A) Experimental protocol for the administration of AAV9-Tert and AAV9-empty virus. 27–30-wk-old Tert+/+ and G3 Tert−/− mice were administered with 2E12vg of AAV9-Tert and AAV9-empty virus by intravenous tail injection. Animals were sacrificed 21 wk later for lung tissue harvesting. (B) Total lung mRNA levels of Tert normalized to 18S expression in AAV9-empty– and AAV9-Tert–treated animals. (C–H) Quantification of mean telomere fluorescence (mean spot intensity; C and E), percentage of short telomeres in ATII and club cells corresponding to the 20th percentile of the fluorescence intensity values of controls (5-wk-old Tert+/+ mice; D and F), and SFTPC-positive ATII cells (%) and SCGB1A1-positive club cells per epithelium length (millimeters) in AAV9-Tert– and AAV9-empty–treated mice (G and H). (I) Representative images showing a Q-FISH for telomere spot fluorescence in ATII and club cells (Cy3Tel probe [red], SFTPC- and SCGB1A1-positive cells [green], and nuclei stained with DAPI [blue]; left and center right), and SFTPC (brown, red arrowheads; center left) and SCGB1A1 (brown, green arrowheads; right) immunostainings in lung sections from Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels) virus. (J–L) Changes in total lung mRNA expression levels of the surfactant markers Sftpa1, Sftpc, and Sftpd normalized to 18S expression. Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.](https://figures.cochat.ai/paper-figures/cc6fac0ba4b4469c8190b9aaa0069ff7/telomerase-treatment-prevents-lung-profibrotic-pathologies-associated-with-figure-6.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistently, expression of telomerase using adeno-associated vectors (AAVs) in alveolar epithelial type II cells led to TAF reduction, decreased inflammation and improved lung function in telomerase-mutant and wild-type aged mice63,64.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [64]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In various murine liver injury models, stellate cells can acquire senescence markers, including p21, p16, and SA-β-gal, and express certain SASP factors80–83.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [80]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Self-citationRaghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“In mammals, telomeric DNA consists of TTAGGG repeats bound by a six-protein complex termed “shelterin” (Liu et al., 2004; de Lange, 2005).”
BackgroundAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 1×
“Previous authors have also suggested a role for senescence in IPF (Selman and Pardo, 2014; Spagnolo et al., 2015; Pardo and Selman, 2017; Campisi, 2013).”
BackgroundA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108 · cited 1×
“To this end, we performed a full characterization of mouse lungs at different ages (5, 8–9, 42–49, and 92–125 wk of age) in both wild-type and third-generation (G3) telomerase-deficient mice with short telomeres (Blasco et al., 1997) as a control for lung pathologies associated with accelerated telomere shortening (Fi…”
MethodSelf-citationSwitching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107 · cited 1×
“Telomeres are protective structures at the ends of eukaryotic chromosomes that are essential for chromosome stability (Blackburn, 2001).”
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020 · cited 2×
“IPF affects ∼3 million people worldwide with a median survival time from diagnosis of 2–4 yr (Martinez et al., 2017; Richeldi et al., 2017; Raghu et al., 2018).”
BackgroundOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847 · cited 1×
“Telomeres shorten due to the incomplete replication of DNA ends with each cell division, a phenomenon known as the “end-replication” problem (Watson, 1972; Olovnikov, 1973).”
BackgroundChemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
WATSON, J. D. (1972) · Nature New Biology · doi:10.1038/newbio239197a0 · Cited by 1,632 · cited 1×
“Telomeres shorten due to the incomplete replication of DNA ends with each cell division, a phenomenon known as the “end-replication” problem (Watson, 1972; Olovnikov, 1973).”
BackgroundIntravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456
DNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 3×
“Telomere shortening with age is considered one of the primary hallmarks of aging, and the presence of critically short telomeres owing to mutations in telomerase genes is associated with familial cases of IPF (Alder et al., 2008; Armanios et al., 2007; Tsakiri et al., 2007; Fingerlin et al., 2013; Cronkhite et al., 20…”
BackgroundAlveolar progenitor and stem cells in lung development, renewal and cancer
Desai, T. J., Brownfield, D. G., & Krasnow, M. A. (2014) · Nature · doi:10.1038/nature12930 · Cited by 1,060 · cited 2×
“To this end, we quantified different lung cell types previously shown to be important for lung regeneration, such as ATII cells (positive for the surfactant protein C–SFTPC marker) and club cells (positive for the secretoglobin 1A1-SCGB1A1 marker; Giangreco et al., 2002; Rock et al., 2011; Guha et al., 2012; Desai et…”
BackgroundMethodRock, J. R., Barkauskas, C. E., Cronce, M. J., Xue, Y., Harris, J. R., Liang, J., Noble, P. W., & Hogan, B. L. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117988108 · Cited by 1,030
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982 · cited 1×
“than normal healthy individuals (Tsang et al., 2012; Armanios and Blackburn, 2012; Armanios, 2013), and mice also show”
BackgroundIdentification of seven loci affecting mean telomere length and their association with disease
CARDIoGRAM consortium, Codd, V., Nelson, C. P., Albrecht, E., Mangino, M., Deelen, J., Buxton, J. L., Hottenga, J. J., Fischer, K., Esko, T., et al. (2013) · Nature Genetics · doi:10.1038/ng.2528 · Cited by 933
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894
Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging
Blackburn, E. H., Greider, C. W., & Szostak, J. W. (2006) · Nature Medicine · doi:10.1038/nm1006-1133 · Cited by 880 · cited 1×
“Critically short telomeres with aging are considered one of primary hallmarks of aging, since they can trigger other hallmarks of aging, such as genomic instability, cellular senescence, and apoptosis, mitochondrial dysfunction and loss of the regenerative capacity of tissues (Blasco, 2005; Blackburn et al., 2006; Lóp…”
BackgroundHogan, B. L. M., Barkauskas, C. E., Chapman, H. A., Epstein, J. A., Jain, R., Hsia, C. C. W., Niklason, L., Calle, E., Le, A., Randell, S. H., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.07.012 · Cited by 876
Rawlins, E. L., Okubo, T., Xue, Y., Brass, D. M., Auten, R. L., Hasegawa, H., Wang, F., & Hogan, B. L. M. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.04.002 · Cited by 853
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805 · cited 4×
“In agreement with IPF being an age-associated disease, IPF patients present most of the hallmarks of aging including abnormal shortening of telomeres, genomic instability, mitochondrial dysfunction, increased oxidative stress, and senescence (Meiners et al., 2015; Selman and Pardo, 2014; Alder et al., 2008; Demopoulos…”
BackgroundInfluentialTelomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747 · cited 1×
“Thus, these results presented here support the notion that telomere shortening with aging can impair the ability of stem cells to regenerate tissues (Blasco, 2007; Flores et al., 2008).”
ResultSelf-citationHow stem cells age and why this makes us grow old
Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 743
An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics
Angelidis, I., Simon, L. M., Fernandez, I. E., Strunz, M., Mayr, C. H., Greiffo, F. R., Tsitsiridis, G., Ansari, M., Graf, E., Strom, T.-M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08831-9 · Cited by 637
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74942 · Cited by 627 · cited 1×
“In agreement with IPF being an age-associated disease, IPF patients present most of the hallmarks of aging including abnormal shortening of telomeres, genomic instability, mitochondrial dysfunction, increased oxidative stress, and senescence (Meiners et al., 2015; Selman and Pardo, 2014; Alder et al., 2008; Demopoulos…”
BackgroundTissue damage and senescence provide critical signals for cellular reprogramming in vivo
Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., et al. (2016) · Science · doi:10.1126/science.aaf4445 · Cited by 589 · cited 1×
“As previously described by us, telomerase-deficient mice secret higher cytokine levels than wild-type mice (Mosteiro et al., 2016).”
BackgroundSelf-citationTelomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., & Kim Garcia, C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-550oc · Cited by 573 · cited 1×
“Telomere shortening with age is considered one of the primary hallmarks of aging, and the presence of critically short telomeres owing to mutations in telomerase genes is associated with familial cases of IPF (Alder et al., 2008; Armanios et al., 2007; Tsakiri et al., 2007; Fingerlin et al., 2013; Cronkhite et al., 20…”
BackgroundBernardes de Jesus, B., Vera, E., Schneeberger, K., Tejera, A. M., Ayuso, E., Bosch, F., & Blasco, M. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200245 · Cited by 548
Self-citationGiangreco, A., Reynolds, S. D., & Stripp, B. R. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64169-7 · Cited by 544
Lung regeneration: mechanisms, applications and emerging stem cell populations
Kotton, D. N., & Morrisey, E. E. (2014) · Nature Medicine · doi:10.1038/nm.3642 · Cited by 515
Adeno-associated virus vectors can be efficiently produced without helper virus
Matsushita, T., Elliger, S., Elliger, C., Podsakoff, G., Villarreal, L., Kurtzman, G., Iwaki, Y., & Colosi, P. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300680 · Cited by 500 · cited 1×
“Viral particle production and treatment Viral vectors were generated by triple transfection of HEK293 cells and purified as previously described (Matsushita et al., 1998; Ayuso et al., 2010).”
MethodPulmonary macrophages: key players in the innate defence of the airways
Byrne, A. J., Mathie, S. A., Gregory, L. G., & Lloyd, C. M. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207020 · Cited by 484 · cited 1×
“Tissue-resident AMs are the most numerous immune cells present in the lung and have a key role in lung homeostasis by protecting the lung during tissue damage (Higashimoto et al., 1993; Boyd et al., 2012; Hussell and Bell, 2014; Byrne et al., 2015; Wong et al., 2017; Angelidis et al., 2019).”
BackgroundDisease states associated with telomerase deficiency appear earlier in mice with short telomeres
Herrera, E., Samper, E., Martín‐Caballero, J., Flores, J. M., Lee, H., & Blasco, M. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.2950 · Cited by 471
Self-citationTelomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468
Self-citationSelman, M., & Pardo, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2221pp · Cited by 454
Effects of Telomerase and Telomere Length on Epidermal Stem Cell Behavior
Flores, I., Cayuela, M. L., & Blasco, M. A. (2005) · Science · doi:10.1126/science.1115025 · Cited by 448
Self-citationTelosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric Proteins
Liu, D., O'Connor, M. S., Qin, J., & Songyang, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409293200 · Cited by 405 · cited 1×
“In mammals, telomeric DNA consists of TTAGGG repeats bound by a six-protein complex termed “shelterin” (Liu et al., 2004; de Lange, 2005).”
BackgroundMacrophages: friend or foe in idiopathic pulmonary fibrosis?
Zhang, L., Wang, Y., Wu, G., Xiong, W., Gu, W., & Wang, C.-Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0864-2 · Cited by 375
The longest telomeres: a general signature of adult stem cell compartments
Flores, I., Canela, A., Vera, E., Tejera, A., Cotsarelis, G., & Blasco, M. A. (2008) · Genes & Development · doi:10.1101/gad.451008 · Cited by 352
Self-citationTelomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347 · cited 2×
“2020 Vol. 219 No. 10 e202002120 Armanios and Blackburn, 2012; Armanios, 2013).”
BackgroundMeiners, S., Eickelberg, O., & Königshoff, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00186914 · Cited by 340 · cited 2×
“In agreement with IPF being an age-associated disease, IPF patients present most of the hallmarks of aging including abnormal shortening of telomeres, genomic instability, mitochondrial dysfunction, increased oxidative stress, and senescence (Meiners et al., 2015; Selman and Pardo, 2014; Alder et al., 2008; Demopoulos…”
BackgroundEpidemiology of idiopathic pulmonary fibrosis
Ley, B., & Collard, H. (2013) · Clinical Epidemiology · doi:10.2147/clep.s54815 · Cited by 321 · cited 1×
“, 2012; Selman and Pardo, 2014), its global incidence is predicted to increase in association with the worldwide phenomenon of demographic aging (Ley and Collard, 2013).”
BackgroundForced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib
Karimi-Shah, B. A., & Chowdhury, B. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500526 · Cited by 316
Kovacs, E., Lowery, E., Kuhlmann, E., & Brubaker, A. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s51152 · Cited by 274
Ayuso, E., Mingozzi, F., Montane, J., Leon, X., Anguela, X. M., Haurigot, V, Edmonson, S. A., Africa, L., Zhou, S., High, K. A., et al. (2010) · Gene Therapy · doi:10.1038/gt.2009.157 · Cited by 272 · cited 1×
“Viral particle production and treatment Viral vectors were generated by triple transfection of HEK293 cells and purified as previously described (Matsushita et al., 1998; Ayuso et al., 2010).”
MethodSelf-citationAbnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
Faner, R., Rojas, M., MacNee, W., & Agustí, A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0282pp · Cited by 268
The therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi, V., Chaudhuri, N., Torrisi, S. E., Kahn, N., Müller, V., & Kreuter, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0021-2019 · Cited by 265
Samper, E., Flores, J. M., & Blasco, M. A. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve174 · Cited by 263 · cited 1×
“…in wild-type lungs, and this is anticipated in telomerase-deficient mice Accumulation of cells with DNA damage is associated with aging, as well as with the presence of short telomeres in mice (López-Ot́ın et al., 2013; Herrera et al., 1999b; Samper et al., 2001; Bernardes de Jesus et al., 2012).”
BackgroundSelf-citationSun, L., Louie, M. C., Vannella, K. M., Wilke, C. A., LeVine, A. M., Moore, B. B., & Shanley, T. P. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00122.2010 · Cited by 251 · cited 1×
“In this sense, overexpression of IL-6 and IL-10 were reported to impact the polarization of profibrotic M2 macrophages (Sun et al., 2011; Ayaub et al., 2017).”
BackgroundAging Impairs Alveolar Macrophage Phagocytosis and Increases Influenza-Induced Mortality in Mice
Wong, C. K., Smith, C. A., Sakamoto, K., Kaminski, N., Koff, J. L., & Goldstein, D. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700397 · Cited by 246 · cited 1×
“Tissue-resident AMs are the most numerous immune cells present in the lung and have a key role in lung homeostasis by protecting the lung during tissue damage (Higashimoto et al., 1993; Boyd et al., 2012; Hussell and Bell, 2014; Byrne et al., 2015; Wong et al., 2017; Angelidis et al., 2019).”
BackgroundThe telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo
Liu, Y., Snow, B. E., Hande, M. P., Yeung, D., Erdmann, N. J., Wakeham, A., Itie, A., Siderovski, D. P., Lansdorp, P. M., Robinson, M. O., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00805-8 · Cited by 244 · cited 1×
“(Liu et al., 2000) and backcrossed to >98% C57/BL6 background.”
Ahluwalia, N., Shea, B. S., & Tager, A. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0509pp · Cited by 235
Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction
Povedano, J. M., Martinez, P., Flores, J. M., Mulero, F., & Blasco, M. A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.028 · Cited by 225
Self-citationHou, J., Shi, J., Chen, L., Lv, Z., Chen, X., Cao, H., Xiang, Z., & Han, X. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0300-8 · Cited by 202
Telomerase mutations in smokers with severe emphysema
Stanley, S. E., Chen, J. J. L., Podlevsky, J. D., Alder, J. K., Hansel, N. N., Mathias, R. A., Qi, X., Rafaels, N. M., Wise, R. A., Silverman, E. K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78554 · Cited by 196
Tompkins, D. H., Besnard, V., Lange, A. W., Wert, S. E., Keiser, A. R., Smith, A. N., Lang, R., & Whitsett, J. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008248 · Cited by 176
Plantier, L., Crestani, B., Wert, S. E., Dehoux, M., Zweytick, B., Guenther, A., & Whitsett, J. A. (2011) · Thorax · doi:10.1136/thx.2010.151555 · Cited by 176
DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease
Birch, J., Anderson, R. K., Correia-Melo, C., Jurk, D., Hewitt, G., Marques, F. M., Green, N. J., Moisey, E., Birrell, M. A., Belvisi, M. G., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00293.2015 · Cited by 174
Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging
Blasco, M. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600598 · Cited by 164 · cited 1×
“…one of primary hallmarks of aging, since they can trigger other hallmarks of aging, such as genomic instability, cellular senescence, and apoptosis, mitochondrial dysfunction and loss of the regenerative capacity of tissues (Blasco, 2005; Blackburn et al., 2006; López-Ot́ın et al., 2013).”
BackgroundSelf-citationSchürch, D., Ospina, O. L., Cruz, A., & Pérez‐Gil, J. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.09.039 · Cited by 162
Self-citationTherapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells
Jakubzick, C., Choi, E. S., Joshi, B. H., Keane, M. P., Kunkel, S. L., Puri, R. K., & Hogaboam, C. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2684 · Cited by 157
Brandenberger, C., & Mühlfeld, C. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2511-x · Cited by 152 · cited 1×
“In the case of the lungs, aging causes a progressive impairment of lung function, including structural and immunological alterations that can impair the respiratory function and increase the risk of lung diseases (Lowery et al., 2013; Brandenberger and Mühlfeld, 2017).”
BackgroundGuha, A., Vasconcelos, M., Cai, Y., Yoneda, M., Hinds, A., Qian, J., Li, G., Dickel, L., Johnson, J. E., Kimura, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204710109 · Cited by 148
Telomere shortening in mTR−/− embryos is associated with failure to close the neural tube
Herrera, E., Samper, E., & Blasco, M. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1172 · Cited by 147 · cited 2×
“We could obtain very old (92–125 wk) Tert+/+ mice, but not G3 Tert−/− mice, owing to the fact that the latter have a shortened life span (Herrera et al., 1999a).”
BackgroundSelf-citationPovedano, J. M., Martinez, P., Serrano, R., Tejera, Á., Gómez-López, G., Bobadilla, M., Flores, J. M., Bosch, F., & Blasco, M. A. (2018) · eLife · doi:10.7554/elife.31299 · Cited by 139
Self-citationUnderstanding the principle biophysics concepts of pulmonary surfactant in health and disease
Autilio, C., & Pérez‐Gil, J. (2018) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2018-315413 · Cited by 123 · cited 2×
“already used surfactant at the air–liquid interface with a limited biophysical performance (Autilio and Pérez-Gil, 2019).”
MethodSelf-citationTelomere Length in Interstitial Lung Diseases
Snetselaar, R., van Moorsel, C. H. M., Kazemier, K. M., van der Vis, J. J., Zanen, P., van Oosterhout, M. F. M., & Grutters, J. C. (2015) · CHEST Journal · doi:10.1378/chest.14-3078 · Cited by 122
Ayaub, E. A., Dubey, A., Imani, J., Botelho, F., Kolb, M. R. J., Richards, C. D., & Ask, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-13511-z · Cited by 120 · cited 1×
“In this sense, overexpression of IL-6 and IL-10 were reported to impact the polarization of profibrotic M2 macrophages (Sun et al., 2011; Ayaub et al., 2017).”
BackgroundBoyd, A. R., Shivshankar, P., Jiang, S., Berton, M. T., & Orihuela, C. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.04.004 · Cited by 117
Cellular senescence in the lung across the age spectrum
Parikh, P., Wicher, S., Khandalavala, K., Pabelick, C. M., Britt, R. D., & Prakash, Y. S. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00424.2018 · Cited by 112
Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice
Liu, T., Chung, M. J., Ullenbruch, M., Yu, H., Jin, H., Hu, B., Choi, Y. Y., Ishikawa, F., & Phan, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32369 · Cited by 104 · cited 1×
“This is interesting, because previous studies have failed to detect lung fibrosis in the telomerasedeficient mouse model (Liu et al., 2007; Lee et al., 2009; Degryse et al., 2012).”
ResultEpithelial Stress and Apoptosis Underlie Hermansky-Pudlak Syndrome–associated Interstitial Pneumonia
Mahavadi, P., Korfei, M., Henneke, I., Liebisch, G., Schmitz, G., Gochuico, B. R., Markart, P., Bellusci, S., Seeger, W., Ruppert, C., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1414oc · Cited by 98 · cited 1×
“As described for both healthy mice (Mahavadi et al., 2010) and neonates without lung disease (Autilio et al.”
BackgroundIdiopathic pulmonary fibrosis: Recent advances on pharmacological therapy
Spagnolo, P., Maher, T. M., & Richeldi, L. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.04.005 · Cited by 94 · cited 1×
“Previous authors have also suggested a role for senescence in IPF (Selman and Pardo, 2014; Spagnolo et al., 2015; Pardo and Selman, 2017; Campisi, 2013).”
BackgroundDemopoulos, K., Arvanitis, D. A., VASSILAKIS, D. A., Siafakas, N. M., & Spandidos, D. A. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00188.x · Cited by 86 · cited 1×
“…most of the hallmarks of aging including abnormal shortening of telomeres, genomic instability, mitochondrial dysfunction, increased oxidative stress, and senescence (Meiners et al., 2015; Selman and Pardo, 2014; Alder et al., 2008; Demopoulos et al., 2002; Bueno et al., 2015; Korfei et al., 2013).”
BackgroundLung alveolar integrity is compromised by telomere shortening in telomerase-null mice
Lee, J., Reddy, R., Barsky, L., Scholes, J., Chen, H., Shi, W., & Driscoll, B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90411.2008 · Cited by 75 · cited 1×
“This is interesting, because previous studies have failed to detect lung fibrosis in the telomerasedeficient mouse model (Liu et al., 2007; Lee et al., 2009; Degryse et al., 2012).”
ResultKorfei, M., von der Beck, D., Henneke, I., Markart, P., Ruppert, C., Mahavadi, P., Ghanim, B., Klepetko, W., Fink, L., Meiners, S., et al. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.04.033 · Cited by 72
Surfactant dysfunction during overexpression of TGF-β1 precedes profibrotic lung remodeling in vivo
López-Rodríguez, E., Boden, C., Echaide, M., Pérez‐Gil, J., Kolb, M., Gauldie, J., Maus, U. A., Ochs, M., & Knudsen, L. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00065.2016 · Cited by 58
Self-citationA New Hope for Idiopathic Pulmonary Fibrosis
Hunninghake, G. M. (2014) · New England Journal of Medicine · doi:10.1056/nejme1403448 · Cited by 57 · cited 1×
“Indeed, pirfenidone and nintedanib show anti-inflammatory and antifibrotic activity and slow IPF progression, but they are not curative (Ahluwalia et al., 2014; King et al., 2014; Hunninghake, 2014; Karimi-Shah and Chowdhury, 2015).”
BackgroundLiu, Y., Shi, Y., Liu, Y., Pan, X., & Zhang, K. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0007-9 · Cited by 57 · cited 1×
“A role for short/dysfunctional telomeres at the origin of IPF is also supported by genetically modified mouse models with mutations in telomerase or telomere maintenance genes (Povedano et al., 2015; Liu et al., 2018).”
BackgroundLiu, G., Zhai, H., Zhang, T., Li, S., Li, N., Chen, J., Gu, M., Qin, Z., & Liu, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109230 · Cited by 55
Telomerase deficiency does not alter bleomycin-induced fibrosis in mice
Degryse, A. L., Xu, X. C., Newman, J. L., Mitchell, D. B., Tanjore, H., Polosukhin, V. V., Jones, B. R., McMahon, F. B., Gleaves, L. A., Phillips, J. A., et al. (2012) · Experimental Lung Research · doi:10.3109/01902148.2012.658148 · Cited by 54 · cited 1×
“This is interesting, because previous studies have failed to detect lung fibrosis in the telomerasedeficient mouse model (Liu et al., 2007; Lee et al., 2009; Degryse et al., 2012).”
ResultThe effects of aging on the function of alveolar macrophages in mice
Higashimoto, Y., Fukuchi, Y., Shimada, Y., Ishida, K., Ohata, M., Furuse, T., Shu, C., Teramoto, S., Matsuse, T., Sudo, E., et al. (1993) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(93)90024-l · Cited by 53
Canela, A., Klatt, P., & Blasco, M. A. (2007) · Methods in Molecular Biology · doi:10.1007/978-1-59745-361-5_5 · Cited by 49 · cited 1×
“measure telomeres in ATII and club cells with aging (Povedano et al., 2018; Canela et al., 2007; Flores et al., 2008).”
BackgroundSelf-citationSurfactant Injury in the Early Phase of Severe Meconium Aspiration Syndrome
Autilio, C., Echaide, M., Shankar‐Aguilera, S., Bragado, R., Amidani, D., Salomone, F., Pérez‐Gil, J., & Luca, D. D. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0413oc · Cited by 49 · cited 2×
“, 2010) and neonates without lung disease (Autilio et al., 2020), the levels of SP-B and SP-C at the extracellular lavage exhibit a substantial variability in the control group.”
BackgroundMethodSelf-citationTsang, A. R., Wyatt, H. D. M., Ting, N. S. Y., & Beattie, T. L. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00810.x · Cited by 46 · cited 1×
“than normal healthy individuals (Tsang et al., 2012; Armanios and Blackburn, 2012; Armanios, 2013), and mice also show”
BackgroundMuñoz-Lorente, M. A., Martínez, P., Tejera, Á., Whittemore, K., Moisés-Silva, A. C., Bosch, F., & Blasco, M. A. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007562 · Cited by 40 · cited 1×
“Moreover, we recently demonstrated AAV9Tert therapy did not lead to an increase in cancer incidence or earlier onset of cancer in mice (Muñoz-Lorente et al., 2018).”
BackgroundSelf-citationAutilio, C., Echaide, M., Luca, D. D., & Pérez‐Gil, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192295 · Cited by 34 · cited 1×
“Pulmonary surfactant isolation and activity Surfactant was collected from bronchoalveolar lavages of mice lungs as described before (Autilio et al., 2018).”
MethodSelf-citationChuang, H.-M., Ho, L.-I., Huang, M., Huang, K.-L., Chiou, T., Lin, S., Su, H.-L., & Harn, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103024 · Cited by 15 · cited 1×
“, 2009), which is increased in bleomycininduced pulmonary fibrosis in mice (Chuang et al., 2018), as well as in patients suffering from IPF (Plantier et al.”
BackgroundFamilial Interstitial Pulmonary Fibrosis: A Large Family with Atypical Clinical Features
Chibbar, R., Gjevre, J. A., Shih, F., Neufeld, H., Lemire, E. G., Fladeland, D. A., & Cockcroft, D. W. (2010) · Canadian Respiratory Journal · doi:10.1155/2010/591523 · Cited by 13 · cited 1×
“Telomere shortening with age is considered one of the primary hallmarks of aging, and the presence of critically short telomeres owing to mutations in telomerase genes is associated with familial cases of IPF (Alder et al., 2008; Armanios et al., 2007; Tsakiri et al., 2007; Fingerlin et al., 2013; Cronkhite et al., 20…”
BackgroundFibroblast Senescence and Apoptosis. “One-Two Punch” to Slow Down Lung Fibrosis?
Pardo, A., & Selman, M. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0387ed · Cited by 7
Research works printed but not linked: 1
- Pardo, 2017, Fibroblast Senescence and Apoptosis, Ajrcmb, 56, 145
Cited by
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Guidelines for minimal information on cellular senescence experimentation in vivo
Ogrodnik, M., Carlos Acosta, J., Adams, P. D., d’Adda di Fagagna, F., Baker, D. J., Bishop, C. L., Chandra, T., Collado, M., Gil, J., Gorgoulis, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.059 · Cited by 376
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Mei, Q., Liu, Z., Zuo, H., Yang, Z., & Qu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.797292 · Cited by 360
Pardo, A., & Selman, M. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0373ps · Cited by 117
Metadata
- Authors
- Piñeiro-Hermida, S., Autilio, C., Martínez, P., Bosch, F., Pérez-Gil, J., & Blasco, M. A.
- Affiliations
- Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre, Madrid, Spain 1
- Universidad Complutense de Madrid (ES)
- Spanish National Cancer Research Centre (ES)
- Universitat Autònoma de Barcelona (ES)
- Department of Biochemistry and Molecular Biology, Research Institute “Hospital 12 de Octubre (imas12),” Complutense University, Madrid, Spain 2
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2020-08-10
- Volume
- 219
- Issue
- 10
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC7659728
- OpenAlex
- W3048397235
- Cited by
- 60
- References
- 99
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 12 · 2020: 3
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Library Open Repository (Universidad Complutense Madrid) (submittedVersion, cc-by-nc-sa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc-nd)
- RIUR (Universidad de La Rioja) (submittedVersion, other-oa)
- Funders
- Spanish Ministry of Economy and Competitiveness (SAF2013-45111-R, SAF2015-72455-EXP)
- Comunidad de Madrid Project (S2017/BMD-3770)
- World Cancer Research Fund (16-1177)
- Spanish Ministry of Science and Innovation (RTI2018-094564-B-100, DTS17/ 00152, SAF2017-82623-R)
- Regional Government of Madrid (P2018/NMT-4389)
- Fundación Botín
- Fundación Banco Santander
- Instituto de Salud Carlos III
- European Regional Development Fund
- Spanish Estate Research Agency
- RyPSE-CM (B2017/BMD-3770)
- Community of Madrid
- European Social Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- telomerase, idiopathic pulmonary fibrosis, physiological aging, telomere shortening, pulmonary fibrosis, cellular senescence, alveolar type II cells, Clara cells, fibroblast activation, collagen deposition, DNA damage
- MeSH terms
- Aging, Animals, Bleomycin, Disease Models, Animal, DNA Damage, Humans, Lung, Telomere, Cellular Senescence, Mice, Knockout, Telomerase, Mice, Idiopathic Pulmonary Fibrosis, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.